Cabometyx
My Prescription
Payment
Select pharmacy
$27,965.12
Print or send this coupon to your phone
AlbertsonsPowered byAbout Cabometyx
Drug Details
Cabozantinib is a medication prescribed for the treatment of different types of cancer. It falls under the category of tyrosine kinase inhibitors and functions by inhibiting or halting the proliferation of cancer cells.
Price history for Cabometyx
30 Tablets, 20MG
Average retail price for Cabometyx
Average SaveHealth price for Cabometyx
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Cabometyx dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 20MG | 30 Tablets | $27,965.12 | $932.17 |
| 40MG | 30 Tablets | $27,965.12 | $932.17 |
| 60MG | 30 Tablets | $27,965.12 | $932.17 |
Cabometyx FAQs
Cabometyx (cabozantinib) is not considered traditional chemotherapy. It is a targeted therapy, specifically a tyrosine kinase inhibitor, used to treat certain types of cancer by blocking specific proteins that promote cancer cell growth.
The success rate of CABOMETYX (cabozantinib) can vary depending on the type and stage of cancer being treated. In clinical trials for advanced renal cell carcinoma, CABOMETYX has shown to improve progression-free survival and overall survival compared to other treatments. For advanced hepatocellular carcinoma, it has also demonstrated efficacy in extending survival. However, individual responses can differ, and it is important for patients to discuss their specific case and potential outcomes with their healthcare provider.
The duration a patient can stay on CABOMETYX (cabozantinib) depends on several factors, including the individual's response to the treatment, the presence of any side effects, and the specific condition being treated. Typically, a healthcare provider will monitor the patient's progress and make adjustments as necessary. Treatment may continue as long as the patient is benefiting from the medication and tolerating it well. It is important for patients to have regular follow-ups with their healthcare provider to assess the effectiveness and safety of the treatment.
It is important for patients to follow their healthcare provider's instructions regarding the use of CABOMETYX. If a patient is considering taking a break from the medication, they should consult their healthcare provider first. The provider can offer guidance based on the patient's specific medical condition and treatment plan.
Cabometyx (cabozantinib) is a medication that can help shrink tumors in certain types of cancer. It is used to treat advanced renal cell carcinoma, hepatocellular carcinoma, and certain cases of thyroid cancer. By inhibiting specific proteins involved in tumor growth and angiogenesis, Cabometyx can reduce tumor size in some patients. However, the effectiveness can vary depending on the individual and the specific cancer type. It is important for patients to discuss treatment options and potential outcomes with their healthcare provider.